This Pharma Stock Eyes Entry As Opioid Addiction Specialist's Profits Surge 108%

Opioid addiction has cast a shadow over the U.S. But pharma stock Indivior Pharmaceuticals is eyeing a fresh entry as profits soar.

Raccontata dainvestors.com